Cravatex Ltd

Consolidated results

• Consolidated revenue from operations: 3,222.45; PAT: 43.81; EPS: 1.70 for quarter ended 30 Jun 2026.
• Total income: 3,662.63 for quarter ended 30 Jun 2026.
• Year ended 2025-26: revenue 15,087.40; PAT 679.67; EPS 26.30.

Notes & governance

• Board approved unaudited results for quarter ended 30 Jun 2026.
• Statutory auditors performed limited review of standalone and consolidated results.
• Group includes BB (UK) Ltd and BB Europe GmbH; results reviewed.
• Group operates only in one primary business segment.

Meeting Details

• Date: 12 August 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone and consolidated financial results for the quarter ended 30 June 2026.

AGM Details

• Date and time: 31 July 2026, 3:30 PM IST; mode: VC/OAVM.
• Remote e-voting window: 28–30 July 2026; attendees allowed to vote at AGM.
• No qualifications in statutory auditor and secretarial auditor reports.
• AGM concluded at 4:10 PM IST; Scrutinizer appointed for e-voting.

Key Resolutions

• Adoption of standalone and consolidated financial statements for FY ended 31 March 2026; outcome: pending.
• Final dividend per equity share of 13 (130%); outcome: pending.
• Re-appointment of director retiring by rotation; outcome: pending.
• Voting results: to be announced within two working days.

Director Changes

• Director retiring by rotation stands for re-appointment as ordinary resolution.

Dematerialisation status

• Processed all dematerialisation requests and confirmed to depositories; securities listed on exchanges.
• Physical certificates for dematerialisation were mutilated and cancelled after verification; depository name substituted as owner within timelines.
• Securities dematerialised have been listed on the stock exchanges where the previous securities are listed.

AGM & KYC updates

• 74th AGM scheduled for 31 July 2026 at 3:30 PM IST via VC/OAVM.
• Weblink and exact navigation path to Annual Report 2025-26 provided.
• Notice issued to unregistered-email members; link to access report shared.
• KYC updates required for physical holders per SEBI circular; electronic payments only.
• KYC formats ISR-1/ISR-2/ISR-3 and SH-13/SH-14 available on MUFG site.
• Physical holders to update PAN, address with PIN, mobile, bank, and nomination.
• Electronic payments mandatory for physical folios from 1 April 2024.
• Reminder to update email addresses by 26 June 2026.
• Dematerialisation of physical securities encouraged.

Financial performance

• Standalone turnover Rs 710 Lakh; up from Rs 480 Lakh.
• PBT Rs 573.88 Lakh; PAT Rs 555.01 Lakh.
• EPS Rs 21.48; YoY growth positive.
• Total comprehensive income Rs 553.35 Lakh; OCI (1.66) Lakh.
• Final dividend Rs 13 per share; outflow Rs 335.94 Lakh.
• Standalone net worth Rs 2380 Lakh; equity Rs 258.42 Lakh; reserves Rs 2122 Lakh.
• Consolidated turnover Rs 16769.33 Lakh; PAT Rs 679.67 Lakh; EPS Rs 26.30.
• Consolidated cash flow: operating Rs 127 Lakh; investing Rs 329 Lakh; financing Rs -323 Lakh; net increase Rs 133 Lakh.
• Dividends paid during year Rs 323.02 Lakh.

Dividends & capital

• Final dividend for 2025-26 Rs 13 per share; subject to shareholder approval.
• Previous year final dividend Rs 12.50 per share paid.
• Shares outstanding 2,584,160; par Rs 10; total paid-up Rs 258.42 Lakh.

Capital & liquidity

• No long-term borrowings; net debt negative Rs 9,534.23 Lakh.
• Net worth Rs 11,943.62 Lakh; equity Rs 258.42 Lakh.
• Current ratio 5.62x; liquidity comfortable.
• Cash & cash equivalents Rs 7,653.74 Lakh; mutual funds Rs 1,872.13 Lakh.

Governance & leadership

• MD Rajesh Batra reappointed for 3 years (2025-06 to 2028-05).
• Executive Director & CFO Divakar Kamath reappointed for 3 years (2026-04 to 2029-03).
• Independent Director Rina Suresh Deora appointed from 20-May-2025; Pheroza Bilimoria ceased 13-Aug-2025.

Subsidiaries & consolidation

• BB UK Ltd: 100% subsidiary; turnover GBP 12.14m; PAT GBP 0.56m; interim dividend Rs 419.45 Lakh.
• BB Europe GmbH: Step-down subsidiary; PAT -0.18m; turnover not disclosed.
• Consolidated results reflect BB UK and BB Europe; 2025-26 turnover Rs 16,769.33 Lakh; PAT Rs 679.67 Lakh.

Related party transactions

• Dividend received from BB UK Ltd Rs 419.45 Lakh.
• Sourcing fee from Future Brands Ltd Rs 933.92 Lakh.
• Combined office/admin charges from Tecfin Consultancy Rs 12.00 Lakh.
• Space & amenities charges from Tecfin Rs 29.40 Lakh.
• Director sitting fees Rs 11.60 Lakh.
• KMP compensation Rs 501.56 Lakh.

Audit & compliance

• Statutory auditors GPS & Associates; Secretarial audit Hemanshu Kapadia; Annexure III included.
• No frauds; no qualifications; internal financial controls adequate and effective.
• CARO reports show no qualifications or material issues.

Risks & outlook

• West Asia conflict may impact trading/logistics; BB UK exposure discussed.
• Management maintains robust risk controls and ongoing internal audit monitoring.

Record date

• Purpose: 74th AGM and final dividend entitlement.
• Security: equity shares.
• Record date: 24 July 2026.
• Final dividend applies if approved by members at the AGM.
• Financial year ended 31 March 2026.